Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 7, 1996, Pages 774-786

  Mirabella, Massimiliano ^a   Alvarez, Renate B ^a   Bilak, Masako ^a   Engel, W King ^a   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Inclusion body myopathies; Inclusion body myositis; Phosphorylated tau

Indexed keywords

EPITOPE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CELL INCLUSION; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MYOPATHY; MYOSITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0029971055     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199607000-00003     Document Type: Article

References (57)

1. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995;7:486-96
2. Engel WK, Cunningham GG. Rapid examination of muscle tissue: An improved trichrome method for fresh-frozen biopsy sections. Neurology 1963;13:919-23
3. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion-body myositis. Arch Neurol 1991;48:1229-34
4. Askanas V, Engel WK, Alvarez RB, Glenner GG. β-amyloid protein immuno-reactivity in muscle of patients with inclusion-body myositis. Lancet 1992;339:560-61
5. Askanas, V, Engel WK, Alvarez RB. Light- and electronmicroscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992;141:31-36
6. Askanas V, Engel WK. New advances in inclusion-body myositis. Curr Opin Rheumatol 1993;5:732-41
7. Askanas V, Engel WK, Alvarez RB. Enhanced detection of congo-red positive amyloid deposits in muscle fibers of inclusion-body myositis and brain of Alzheimer disease using fluorescence technique. Neurology 1993;43:1265-67
8. Askanas V, Engel WK, Bilak M, Alvarez RB, Selkoe DJ. Twisted tubulofilaments of inclusion-body myositis resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994;144:177-87
9. Askanas V, Alvarez RB, Engel WK. Abnormal accumulations of β-amyloid precursor epitopes in muscle fibers of inclusion-body myositis. Ann Neurol 1993;34:551-60
10. Askanas V, Mirabella M, Engel WK, Alvarez RB, Weisgraber K. Apolipoprotein E immunoreactive deposits in inclusion-body muscle disease. Lancet 1994;343:364-65
11. Askanas V, Serdaroglu P, Engel WK, Alvarez RB. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusionbody myositis and oculopharyngeal muscular dystrophy. Neurosci Lett 1991;130:73-76
12. 1-antichymotrypsin colocalizes with β-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropathol 1993;85:378-82
13. Sarkozi E, Askanas V, Johnson SA, Engel WK, Alvarez RB. β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. NeuroReport 1993;4:815-18
14. Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. NeuroReport 1993;5:25-28
15. Sarkozi E, Askanas V, Engel WK. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Am J Pathol 1994;145:1280-84
16. Engel WK. Muscle biopsies in neuromuscular diseases. Pediatr Clin North Am 1967;14:963-96
17. Sternberger LA, Sternberger NH. Monoclonal antibodies distinguish phosphorylated and non-phosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 1983;80:6126-30
18. Sternberger NH, Sternberger LA, Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci USA 1985;82:4274-76
19. Zhang H, Sternberger NH, Rubinstein LJ, Herman MM, Binder LI, Sternberger LA. Abnormal processing of multiple proteins in Alzheimer disease. Proc Natl Acad Sci USA 1989;86:8045-49
20. Ksiezak-Reding H, Dickson DW, Davies P, Yen SH. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 1987;84: 3410-14
21. Nukina N, Kosik KS, Selkoe DJ. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci USA 1987;84: 3415-19
22. Lichtenberg-Kraag B, Mandelkow EM, Biemat J, et al. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci USA 1992;89: 5384-88
23. PHF proteins display the same biochemical profile as normal τ. J Biol Chem 1992;267:564-69
24. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y. Abnormal tau phosphorylation at Ser (396) in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-99
25. Otvos L, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM-Y. The monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. Neurosci Res 1994;39:669-73
26. Mercken M, Vandermeeren M, Lubke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84: 265-72
27. Biernat J, Mandelkow EM, Schroter C, et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule-binding region. EMBO J 1992;11:1593-97
28. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-70
29. Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-70
30. Askanas V, Engel WK. A technique of fiber selection from human muscle tissue cultures for histochemical-electronmicroscopic studies. J Histochem Cytochem 1975:23:144-46
31. Gorycki M, Askanas V. Improved technique for electron microscopy of cultured cells. Stain Technol 1977;52:249-54
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
33. Brion JP, Hanger DP, Couck A-M, Flament-Durand J, Anderton BH. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J 1991;279:831-36
34. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993;16(11):460-65
35. Mandelkow EM, Mandelkow E. Tau as a marker for Alzheimer's disease. Trends in Biochem Sci 1993:18:480-83
36. Kosik KS. The molecular and cellular biology of tau. Brain Pathol 1993;3:39-43
37. Trojanowski JQ, Lee VM-Y. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and lewy body dementias. Ann NY Acad Sci USA 1994;747:92-109
38. Goedert M, Spillantini MG, Jakes R, et al. Molecular dissection of the paired helical filament. Neurobiol Aging 1995;16:325-34
39. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-68
40. Braak E, Braak H, Mandelkow E-M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-67
41. Su JH, Cummings BJ, Cotman CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. NeuroReport 1994;5:2358-62
42. Mandelkow EM, Biernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol Aging 1995;16(3):355-63
43. Smith MA, Taneda S, Richey PL, et al. Advanced maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-14
44. Ledesma MD, Bonay P, Avila J. Protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 1995;65:1-7
45. Smith MA, Sayre LM, Monnier VM, Perry G. Radical Ageing in Alzheimer's disease. Trends Neurosci 1995;18:172-76
46. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
47. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-26
48. Goedert M, Spillantini MG, Jakes R. Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau. Neurosci Lett 1991;126:149-54
49. Ihara Y, Abraham C, Selkoe DJ. Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 1983;304:727-30
50. Mori H, Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987;235:1641-44
51. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 1993;10:1151-60
52. Ksiezak-Reding H, Dickson DW, Davies P, Yen S-H. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 1987;84: 3410-14
53. Schmidt ML, Lee VM-Y, Trojanowski JQ. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am J Pathol 1990;136:1069-75
54. Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res 1992;594:273-78
55. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol 1988;77:113-19
56. Schweers D, Schönbrunn-Hanebeck E, Marx A, Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence of β-structure. J Biol Chem 1994;269: 24290-97
57. Schweers D, Mandelkow EM, Biernat J, Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 1995;92:8463-67